EMR vs OTIS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

EMR

53.0
AI Score
VS
EMR Wins

OTIS

25.7
AI Score

Investment Advisor Scores

EMR

Nov 04, 2026
53score
Recommendation
HOLD

OTIS

Nov 04, 2026
26score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR OTIS Winner
Forward P/E 20.4918 17.452 OTIS
PEG Ratio 1.6989 1.8363 EMR
Revenue Growth 7.0% 6.1% EMR
Earnings Growth 23.0% 13.7% EMR
Tradestie Score 53.0/100 25.7/100 EMR
Profit Margin 13.8% 10.3% EMR
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

EMR 1M: +5.6% · 3M: +8.6% OTIS 1M: +20.1% · 3M: +8.1%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 64

RSI (14): 64.4 · Price: $170.44

OTIS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.7 · Price: $79.79

Fundamentals Snapshot

Metric EMR OTIS
Market Cap — —
Forward P/E 23.5 17.8
Trailing P/E 36.3 19.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.3% 0.2%
EPS 4.58 3.94
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.